Thyroid hormone transporters and deiodinases in the developing human hypothalamus

European Journal of Endocrinology

Volumn 167, Issue 3, 2012, Pages 379-386

  Friesema, Edith C H ^a   Visser, Theo J ^a   Borgers, Anke J ^b   Kalsbeek, Andries ^b,c   Swaab, Dick F ^c   Fliers, Eric ^b   Alkemade, Anneke ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DEIODINASE 2; DEIODINASE 3; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 10; MONOCARBOXYLATE TRANSPORTER 8; ORGANIC ANION TRANSPORTING POLYPEPTIDE 1C1; OXIDOREDUCTASE; THYROID HORMONE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DEVELOPMENT; CHILD; CLINICAL ARTICLE; CONGENITAL HYPOTHYROIDISM; DEGRADATION; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; INFANT; MALE; PRENATAL PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BIOLOGICAL TRANSPORT; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPOTHALAMUS; INFANT; INFANT, NEWBORN; IODIDE PEROXIDASE; MALE; MONOCARBOXYLIC ACID TRANSPORTERS; ORGANIC ANION TRANSPORTERS; THYROID HORMONES;

EID: 84865785750     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0177     Document Type: Article

References (42)

1. Bernal J. Thyroid hormones and brain development. Vitamins and Hormones 2005 71 95-122.
2. de Escobar GM, Obregon MJ & del Rey FE. Maternal thyroid hormones early in pregnancy and fetal brain development. Best Practice & Research. Clinical Endocrinology & Metabolism 2004 18 225-248. (doi:10.1016/j.beem. 2004.03.012)
3. Iskaros J, Pickard M, Evans I, Sinha A, Hardiman P & Ekins R. Thyroid hormone receptor gene expression in first trimester human fetal brain. Journal of Clinical Endocrinology and Metabolism 2000 85 2620-2623. (doi:10.1210/jc.85. 7.2620)
4. Delange F. Iodine requirements during pregnancy, lactation and the neonatal period and indicators of optimal iodine nutrition. Public Health Nutrition 2007 10 1571-1580. (doi:10.1017/S1368980007360941)
5. Zoeller RT & Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. Journal of Neuroendocrinology 2004 16 809-818. (doi:10.1111/j.1365-2826.2004.01243.x)
6. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP & Visser TJ. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. Journal of Biological Chemistry 2003 278 40128-40135. (doi:10.1074/jbc.M300909200)
7. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH & Visser TJ. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Molecular Endocrinology 2008 22 1357-1369. (doi:10.1210/me.2007-0112)
8. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G & Meier PJ. Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Molecular Endocrinology 2002 16 2283-2296. (doi:10.1210/me.2001-0309)
9. Friesema EC, Visser WE & Visser TJ. Genetics and phenomics of thyroid hormone transport by MCT8. Molecular and Cellular Endocrinology 2010 322 107-113. (doi:10.1016/j.mce.2010.01.016)
10. Alkemade A, Friesema EC, Kalsbeek A, Swaab DF, Visser TJ & Fliers E. Expression of thyroid hormone transporters in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 2011 96 E967-E971. (doi:10.1210/jc.2010- 2750)
11. Halestrap AP & Meredith D. The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflügers Archiv: European Journal of Physiology 2004 447 619-628. (doi:10.1007/s00424-003-1067-2)
12. Kim DK, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T & Endou H. The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics 2002 79 95-103. (doi:10.1006/geno.2001.6678)
13. Lafreniere RG, Carrel L & Willard HF. A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. Human Molecular Genetics 1994 3 1133-1139. (doi:10.1093/hmg/3.7.1133)
14. Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C & Zerangue N. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 2008 149 6251-6261. (doi:10.1210/en.2008-0378)
15. Galton VA. The roles of the iodothyronine deiodinases in mammalian development. Thyroid 2005 15 823-834. (doi:10.1089/thy.2005.15.823)
16. Obregon MJ, Calvo RM, Del Rey FE & de Escobar GM. Ontogenesis of thyroid function and interactions with maternal function. Endocrine Development 2007 10 86-98. (doi:full-text)
17. Hall JA, Ribich S, Christoffolete MA, Simovic G, Correa-Medina M, Patti ME & Bianco AC. Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis. Endocrinology 2010 151 4573-4582. (doi:10.1210/en.2010-0511)
18. Ng L, Goodyear RJ, Woods CA, Schneider MJ, Diamond E, Richardson GP, Kelley MW, Germain DL, Galton VA & Forrest D. Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. PNAS 2004 101 3474-3479. (doi:10.1073/pnas.0307402101)
19. Ng L, Hernandez A, He W, Ren T, Srinivas M, Ma M, Galton VA, St Germain DL & Forrest D. A protective role for type 3 deiodinase, a thyroid hormone-inactivating enzyme, in cochlear development and auditory function. Endocrinology 2009 150 1952-1960. (doi:10.1210/en.2008-1419)
20. Alkemade A, Friesema EC, Kuiper GG, Wiersinga WM, Swaab DF, Visser TJ & Fliers E. Novel neuroanatomical pathways for thyroid hormone action in the human anterior pituitary. European Journal of Endocrinology 2006 154 491-500. (doi:10.1530/eje.1.02111)
21. Alkemade A, Friesema EC, Unmehopa UA, Fabriek BO, Kuiper GG, Leonard JL, Wiersinga WM, Swaab DF, Visser TJ & Fliers E. Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 2005 90 4322-4334. (doi:10.1210/jc.2004-2567)
22. Diano S, Leonard JL, Meli R, Esposito E & Schiavo L. Hypothalamic type II iodothyronine deiodinase: a light and electron microscopic study. Brain Research 2003 976 130-134. (doi:10.1016/S0006-8993(03)02692-1)
23. Leonard DM, Stachelek SJ, Safran M, Farwell AP, Kowalik TF & Leonard JL. Cloning, expression, and functional characterization of the substrate binding subunit of rat type II iodothyronine 5′-deiodinase. Journal of Biological Chemistry 2000 275 25194-25201. (doi:10.1074/jbc.M002036200)
24. Montero-Pedrazuela A, Bernal J & Guadano-Ferraz A. Divergent expression of type 2 deiodinase and the putative thyroxine-binding protein p29, in rat brain, suggests that they are functionally unrelated proteins. Endocrinology 2003 144 1045-1052. (doi:10.1210/en.2002-220823)
25. Koutcherov Y, Mai JK, Ashwell KW & Paxinos G. Organization of human hypothalamus in fetal development. Journal of Comparative Neurology 2002 446 301-324. (doi:10.1002/cne.10175)
26. Ferreiro B, Bernal J, Goodyer CG & Branchard CL. Estimation of nuclear thyroid hormone receptor saturation in human fetal brain and lung during early gestation. Journal of Clinical Endocrinology and Metabolism 1988 67 853-856. (doi:10.1210/jcem-67-4-853)
27. Kester MH, Martinez de Mena R, Obregon MJ, Marinkovic D, Howatson A, Visser TJ, Hume R & Morreale de Escobar G. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. Journal of Clinical Endocrinology and Metabolism 2004 89 3117-3128. (doi:10.1210/jc.2003-031832)
28. Koutcherov Y, Mai JK & Paxinos G. Hypothalamus of the human fetus. Journal of Chemical Neuroanatomy 2003 26 253-270. (doi:10.1016/j.jchemneu.2003. 07.002)
29. Vulsma T, Gons MH & de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. New England Journal of Medicine 1989 321 13-16. (doi:10.1056/NEJM198907063210103)
30. Fisher DA. Thyroid function in premature infants. The hypothyroxinemia of prematurity. Clinics in Perinatology 1998 25 999-1014.
31. Reuss ML, Leviton A, Paneth N & Susser M. Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. American Journal of Public Health 1997 87 1693-1697. (doi:10.2105/AJPH.87.10.1693)
32. Williams FL, Visser TJ & Hume R. Transient hypothyroxinaemia in preterm infants. Early Human Development 2006 82 797-802. (doi:10.1016/j. earlhumdev.2006.09.007)
33. Alkemade A, Unmehopa UA, Wiersinga WM, Swaab DF & Fliers E. Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus. Journal of Clinical Endocrinology and Metabolism 2005 90 323-327. (doi:10.1210/jc.2004-1430)
34. Fliers E, Guldenaar SE, Wiersinga WM & Swaab DF. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 1997 82 4032-4036. (doi:10.1210/jc.82.12.4032)
35. Murphy N, Hume R, van Toor H, Matthews TG, Ogston SA, Wu SY, Visser TJ & Williams FL. The hypothalamic-pituitary-thyroid axis in preterm infants; changes in the first 24 hours of postnatal life. Journal of Clinical Endocrinology and Metabolism 2004 89 2824-2831. (doi:10.1210/jc.2003-030317)
36. Dumitrescu AM, Liao XH, Best TB, Brockmann K & Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. American Journal of Human Genetics 2004 74 168-175. (doi:10.1086/380999)
37. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP & Visser TJ. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004 364 1435-1437. (doi:10.1016/S0140-6736(04) 17226-7)
38. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ & Stevenson RE. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. American Journal of Human Genetics 2005 77 41-53. (doi:10.1086/431313)
39. Suzuki T & Abe T. Thyroid hormone transporters in the brain. Cerebellum 2008 7 75-83. (doi:10.1007/s12311-008-0029-9)
40. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K & Heuer H. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. Journal of Clinical Investigation 2007 117 627-635. (doi:10.1172/JCI28253)
41. Wirth EK, Roth S, Blechschmidt C, Holter SM, Becker L, Racz I, Zimmer A, Klopstock T, Gailus-Durner V, Fuchs H, Wurst W, Naumann T, Brauer A, de Angelis MH, Kohrle J, Gruters A & Schweizer U. Neuronal 3′,3,5- triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. Journal of Neuroscience 2009 29 9439-9449. (doi:10.1523/JNEUROSCI.6055-08.2009)
42. Chan SY, Martin-Santos A, Loubiere LS, Gonzalez AM, Stieger B, Logan A, McCabe CJ, Franklyn JA & Kilby MD. The expression of thyroid hormone transporters in the human fetal cerebral cortex during early development and in N-Tera-2 neurodifferentiation. Journal of Physiology 2011 589 2827-2845. (doi:10.1113/jphysiol.2011.207290)